Total Valuation
Zura Bio has a market cap or net worth of €480.19M. The enterprise value is €543.01.
Market Cap€480.19M
Enterprise Value€543.01
Share Statistics
Zura Bio has 95,829,140 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding95,829,140
Owned by Insiders8.24%
Owned by Institutions6.76%
Financial Efficiency
Zura Bio’s return on equity (ROE) is -0.68 and return on invested capital (ROIC) is -74.11%.
Return on Equity (ROE)-0.68
Return on Assets (ROA)-0.60
Return on Invested Capital (ROIC)-74.11%
Return on Capital Employed (ROCE)-0.74
Revenue Per Employee0.00
Profits Per Employee-1.72M
Employee Count40
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Zura Bio is ―. Zura Bio’s PEG ratio is -0.06.
PE Ratio―
PS Ratio0.00
PB Ratio4.86
Price to Fair Value4.86
Price to FCF-7.60
Price to Operating Cash Flow-9.21
PEG Ratio-0.06
Income Statement
In the last 12 months, Zura Bio had revenue of 0.00 and earned -68.65M in profits. Earnings per share was -1.06.
Revenue0.00
Gross Profit0.00
Operating Income-75.25M
Pretax Income-68.65M
Net Income-68.65M
EBITDA-68.60M
Earnings Per Share (EPS)-1.06
Cash Flow
In the last 12 months, operating cash flow was -77.55M and capital expenditures -86.00K, giving a free cash flow of -77.63M billion.
Operating Cash Flow-77.55M
Free Cash Flow-77.63M
Free Cash Flow per Share-0.81
Dividends & Yields
Zura Bio pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.16
52-Week Price Change251.82%
50-Day Moving Average4.20
200-Day Moving Average4.30
Relative Strength Index (RSI)54.44
Average Volume (3m)0.00
Important Dates
Zura Bio upcoming earnings date is Nov 18, 2026, Before Open (Confirmed).
Last Earnings DateAug 11, 2026
Next Earnings DateNov 18, 2026
Ex-Dividend Date―
Financial Position
Zura Bio as a current ratio of 9.05, with Debt / Equity ratio of 0.00%
Current Ratio9.05
Quick Ratio9.05
Debt to Market Cap0.00
Net Debt to EBITDA1.59
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Zura Bio has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Zura Bio EV to EBITDA ratio is -5.60, with an EV/FCF ratio of -5.91.
EV to Sales0.00
EV to EBITDA-5.60
EV to Free Cash Flow-5.91
EV to Operating Cash Flow-5.92
Balance Sheet
Zura Bio has €205.13M in cash and marketable securities with €0.00 in debt, giving a net cash position of €205.13M billion.
Cash & Marketable Securities€205.13M
Total Debt€0.00
Net Cash€205.13M
Net Cash Per Share€2.14
Tangible Book Value Per Share€1.08
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Zura Bio is €18.20, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target€18.20
Price Target Upside293.95% Upside
Analyst ConsensusStrong Buy
Analyst Count5
Revenue Growth Forecast―
EPS Growth Forecast-54.86%